CD8A and ovarian cancer: For instance, human cytomegalovirus (HCMV) has been identified as a potential source of immunomodulatory activity in ovarian cancer, with an altered CD8+ T cell to Treg ratio noted and increased immunosuppressive cytokines found in the tumor microenvironment [98].